Reply to Volkman et al. Comment on "Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434"

被引：0
|
作者：
Kohli, Michele [1 ]
Joshi, Keya [2 ]
Beck, Ekkehard [2 ]
Hagiwara, Yuriko [3 ]
Van de Velde, Nicolas [2 ]
Igarashi, Ataru [4 ]
机构：
[1] Quadrant Hlth Econ Inc, 92 Cottonwood Crescent, Cambridge, ON N1T 2J1, Canada
[2] Moderna Inc, 325 Binney St, Cambridge, MA 02142 USA
[3] Moderna Inc, 4-1-1 Toranomon,Kamiyacho,Minato Ku, Tokyo 1056923, Japan
[4] Univ Tokyo, Grad Sch Pharmaceut Sci, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
来源：
VACCINES | 2024年 / 12卷 / 10期
关键词：
coronavirus; SARS-CoV-2; Japan; COVID-19; vaccination; cost-effectiveness;
D O I：
10.3390/vaccines12101175
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Comment on Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434
    Volkman, Hannah R.
    Nguyen, Jennifer L.
    Mustapha, Mustapha M.
    Jodar, Luis
    Mclaughlin, John M.
    VACCINES, 2024, 12 (10)
  • [2] The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan
    Fust, Kelly
    Joshi, Keya
    Beck, Ekkehard
    Maschio, Michael
    Kohli, Michele
    Lee, Amy
    Hagiwara, Yuriko
    van de Velde, Nicolas
    Igarashi, Ataru
    VACCINES, 2024, 12 (04)
  • [3] Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024"
    Hsu, Alan Y.
    Lin, Chun-Ju
    Hsia, Ning-Yi
    Wang, Yu-Hsun
    Li, Jing-Xing
    Chen, Huan-Sheng
    Wei, James Cheng-Chung
    Tsai, Yi-Yu
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (05)
  • [4] Wildlife markets, COVID-19 and totalitarianism: A comment on Cawthorn et al.
    Ronald I. Orenstein
    Ambio, 2021, 50 : 1760 - 1761
  • [5] Wildlife markets, COVID-19 and totalitarianism: A comment on Cawthorn et al.
    Orenstein, Ronald I.
    AMBIO, 2021, 50 (09) : 1760 - 1761
  • [6] Reply to 'Nail psoriasis: A rare mRNA COVID-19 vaccine reaction' by Lamberti A et al.
    Ruggiero, Angelo
    Potestio, Luca
    Battista, Teresa
    Fabbrocini, Gabriella
    Megna, Matteo
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : E41 - E42
  • [7] Comment on 'COVID-19: a major cause of cachexia and sarcopenia' by Morley et al.
    Zhou, Ling
    Liu, Cunming
    Yang, Chun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (01) : 233 - 234
  • [8] The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States
    Kohli, Michele A.
    Maschio, Michael
    Joshi, Keya
    Lee, Amy
    Fust, Kelly
    Beck, Ekkehard
    van de Velde, Nicolas
    Weinstein, Milton C.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1532 - 1545
  • [9] Reply to Grana et al. Comment on "Uzun Ozsahin et al. COVID-19 Prediction Using Black-Box Based Pearson Correlation Approach. Diagnostics 2023, 13, 1264"
    Ozsahin, Dilber Uzun
    Onakpojeruo, Efe Precious
    Duwa, Basil Bartholomew
    Usman, Abdullahi Garba
    Abba, Sani Isah
    Uzun, Berna
    DIAGNOSTICS, 2024, 14 (22)
  • [10] Reply to cinar et al. Comment on "Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874"
    Caruntu, Ana
    Caruntu, Constantin
    Scheau, Cristian
    MEDICINA-LITHUANIA, 2022, 58 (11):
12345